MedPath

Virtual Reality Integrated Social Recovery therapy for Young People with Early Psychosis

Not Applicable
Conditions
Psychosis
Ultra high risk for psychosis
impairment in social cognition
Impairment in social functioning
Psychotic spectrum disorders
Mental Health - Psychosis and personality disorders
Mental Health - Schizophrenia
Mental Health - Anxiety
Registration Number
ACTRN12624000234516
Lead Sponsor
Orygen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
156
Inclusion Criteria

To be considered eligible, a young person must:
1.Meet threshold diagnostic criteria for first episode psychosis (FEP) (defined within DSM-5 all psychotic spectrum disorders or affective disorder with psychotic features who are within their first year of treatment for psychosis) or ultra-high risk for psychosis (UHR) (as assessed by the Comprehensive Assessment of At-Risk Mental State (CAARMS56). Note: this assessment will be conducted by clinicians at the referring clinic and will not form part of the research assessment schedule.
2.Be aged 14 – 30 years
3.Be receiving care from an early psychosis service at the time of recruitment in Melbourne, Adelaide or Perth
4.Have a Social and Occupational Functioning Assessment Scale (SOFAS) score <751

Service providers will be considered eligible for inclusion in this study if they:
1.Work at a participating study site, AND
2.Are responsible for delivering VR-CBT as part of the trial, OR
3,Are responsible for leading a team and or managing the service.

Exclusion Criteria

Young people will not be eligible for participation in this study if any of the below criteria are met:
1.They have cognitive impairment significant enough to impede participation in the study, as determined by treating clinician
2.They have insufficient command of the English language
3.They are currently an inpatient in an acute mental health ward
4.They have current active suicidal plans, with severe and imminent risk to their safety

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br>Social Functioning: The primary outcome will be social functioning as measured by the Social and Occupational Functioning Assessment Scale (SOFAS) post intervention (6 months post treatment)[ Baseline, Week 12 (post treatment), 6mths post treatment, 12mths post treatment]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath